Justo Lorenzo Bermejo | Genetic Epidemiology | Best Researcher Award

Published on 27/05/2026 by Global Academic Awards

Best Researcher Award

Justo Lorenzo Bermejo
University of Heidelberg

Justo Lorenzo Bermejo
Affiliation	University of Heidelberg
Country	Germany
Scopus ID	55665790900
Documents	269
Citations	8,350
h-index	50
Subject Area	Genetic Epidemiology
Event	Global Academic Awards
ORCID	0000-0002-6568-5333

Justo Lorenzo Bermejo of the University of Heidelberg has been acknowledged for sustained academic productivity, extensive publication activity, and measurable citation impact within international research communities.[1] The recognition reflects contributions to epidemiological methodology, genetic risk assessment, and collaborative scientific advancement in health-related disciplines.[2]

Contents

Abstract
Keywords
Introduction
Research Profile
Research Contributions
Publications
Research Impact
Award Suitability
Conclusion
External Links
References

Abstract

This academic recognition article documents the scholarly profile and research achievements of Justo Lorenzo Bermejo, whose work in genetic epidemiology has contributed to scientific understanding of disease susceptibility, population genetics, and epidemiological modeling. The article summarizes publication performance, citation metrics, collaborative research activities, and professional recognition associated with the Best Researcher Award under the Global Academic Awards framework. Emphasis is placed on measurable academic impact, peer-reviewed dissemination, and interdisciplinary scientific engagement.[1][3]

Keywords

Genetic Epidemiology, Biomedical Research, Cancer Genetics, Population Studies, Scientific Citations, Research Metrics, Epidemiological Modeling, Academic Recognition, Global Academic Awards, Genomic Research

Introduction

The Best Researcher Award is intended to acknowledge scholars whose scientific work demonstrates sustained academic productivity, methodological rigor, and international research visibility. Within biomedical sciences, genetic epidemiology has become increasingly important for understanding hereditary disease patterns, environmental interactions, and translational health applications.[4]

Justo Lorenzo Bermejo has contributed to multiple research initiatives involving statistical genetics, cancer epidemiology, and genomic risk analysis. Through collaborations with international institutions and publication in peer-reviewed journals, the researcher has established a record of scholarly engagement supported by significant citation performance and interdisciplinary influence.[2][5]

Research Profile

The research profile of Justo Lorenzo Bermejo reflects extensive scholarly activity in genetic epidemiology and biomedical statistics. The documented publication output includes 269 indexed documents and an h-index of 50, indicating sustained citation influence across multiple scientific domains.[1]

Primary affiliation with the University of Heidelberg, Germany.
Research specialization in genetic epidemiology and population-based health analysis.
Extensive participation in collaborative biomedical research networks.
High citation visibility within epidemiological and genomic research literature.

Research metrics obtained through indexed academic databases indicate substantial international engagement and peer-reviewed dissemination activity.[1]

Research Contributions

The scholarly contributions of Justo Lorenzo Bermejo include analytical investigations into hereditary cancer syndromes, epidemiological risk estimation, and genomic susceptibility factors. Several studies have addressed methodological improvements in population genetics and disease prediction models.

Published research has also examined interactions between environmental exposure and inherited genetic variation, contributing to improved understanding of multifactorial disease processes. These investigations support evidence-based approaches in preventive medicine and public health policy.

Development of epidemiological models for genetic disease assessment.
Contribution to cancer genetics and hereditary risk evaluation studies.
Collaboration in multidisciplinary genomic and biomedical projects.
Publication of peer-reviewed articles with measurable citation impact.

Publications

The publication record associated with Justo Lorenzo Bermejo includes articles in epidemiology, genetics, oncology, and statistical health sciences. Representative publications include studies indexed in international databases and associated with DOI-based scholarly citation systems.[3]

Research concerning hereditary cancer risk and genomic susceptibility analysis.
Studies involving population-level epidemiological data interpretation.
Collaborative investigations into biomedical statistical methodologies.
Peer-reviewed contributions addressing translational genetic medicine.

Examples of DOI-linked scientific literature demonstrate continued engagement with evidence-based biomedical investigation and quantitative epidemiological analysis.

Research Impact

Research impact indicators associated with the academic profile include more than 8,350 citations and a substantial h-index score, reflecting broad utilization of published findings within the scientific community.[1] Citation activity demonstrates continuing relevance in fields connected to epidemiology, genomics, cancer research, and public health analytics.

The influence of the research extends beyond publication metrics through interdisciplinary collaboration, academic mentorship, and participation in international scientific discussions related to biomedical innovation and population health assessment.[5]

Award Suitability

The academic record of Justo Lorenzo Bermejo aligns with the evaluation principles commonly associated with distinguished research recognition programs. Criteria including publication productivity, scholarly citations, international collaboration, and subject-area specialization support suitability for the Best Researcher Award within the Global Academic Awards event framework.[2]

Consistent contribution to peer-reviewed scientific literature.
Recognized impact through citation-based metrics and h-index performance.
Demonstrated interdisciplinary and international research collaboration.
Specialized expertise in genetic epidemiology and biomedical analytics.

Conclusion

The Best Researcher Award article highlights the academic achievements and scientific contributions of Justo Lorenzo Bermejo within the field of genetic epidemiology. The combination of publication productivity, citation impact, collaborative engagement, and methodological research activity reflects a sustained commitment to scholarly advancement and biomedical inquiry.[1]

The documented research profile demonstrates alignment with international standards of academic excellence and supports continued recognition within global scientific and educational communities.

External Links

References

Elsevier. (n.d.). Scopus author details: Justo Lorenzo Bermejo, Author ID 55665790900. Scopus.
https://www.scopus.com/authid/detail.uri?authorId=55665790900
Geographic and genetic diversity in gallbladder cancer mutation profiles: insights from a worldwide exome analysis
https://www.thelancet.com/journals/ebiom/article/PIIS2352-3964(26)00187-8/fulltext
Small-RNA sequencing identifies serum microRNAs associated with abnormal electrocardiography findings in patients with Chagas disease
https://www.sciencedirect.com/science/article/pii/S0163445325002130
International Journal of Epidemiology. (n.d.). Research methodologies in genetic epidemiology.
https://doi.org/10.1093/ije/dyr140
Nature Reviews Genetics. (n.d.). Environmental and genetic determinants of disease.
https://doi.org/10.1038/nrg2817

Victor Wallis | Public Health | Best Researcher Award

Published on 11/10/202511/10/2025 by Global Academic Awards

Prof. Victor Wallis | Public Health | Best Researcher Award

Berklee College of Music | United States

Prof. Victor Wallis, from Berklee College of Music, Boston, United States, is a distinguished researcher specializing in social theory, political economy, and public health. His work critically examines capitalism, socialism, and policy formation, addressing contemporary societal challenges, including the impact of COVID-19 on governance and social structures. With 72 scholarly publications, including open-access articles such as Covid-19 in the History of Capitalism and The Impact of Censorship on COVID-19 Policy Formation in the United States, alongside book chapters in respected outlets like Monthly Review and Socialism and Democracy, Prof. Victor Wallis demonstrates a strong and diverse research portfolio. His scholarship has been cited 203 times across 163 documents, with an h-index of 8, reflecting significant influence and academic recognition. Collaborating with 14 co-authors, his contributions bridge rigorous academic inquiry and social critique, highlighting his relevance and impact in contemporary research, making him a strong candidate for the Best Researcher Award.

Profile: Scopus

Featured Publications

Wallis, V. (2025). Covid-19 in the history of capitalism. Capitalism Nature Socialism.
Wallis, V. (n.d.). Limits to growth
Wallis, V. (n.d.). Katsiaficas, George
Wallis, V. (n.d.). Monthly Review
Wallis, V. (n.d.). Zeitlin, Maurice
Wallis, V. (n.d.). Socialism and Democracy
Wallis, V. (n.d.). The Impact of Censorship on COVID-19 Policy Formation in the United States

Jane Warland | Health Professions | Best Researcher Award

Published on 17/04/202517/04/2025 by Global Academic Awards

Assoc. Prof. Dr. Jane Warland | Health Professions | Best Researcher Award

Assoc. Prof. Dr. Jane Warland, University of Adelaide, Australia

Assoc. Prof. Dr. Jane Elizabeth Warland is a distinguished midwifery academic at the University of Adelaide Medical School, with a clinical title and extensive experience in both academic and clinical settings. With over three decades in maternal health, she has served in various hospitals and held prestigious academic positions across UniSA and Curtin University. Her work bridges clinical care and cutting-edge research, particularly in perinatal health and stillbirth prevention. Dr. Warland is widely respected for her leadership, teaching excellence, and impactful publications. She remains an influential voice in maternal and neonatal care. 🌿📚

Publication Profile

Orcid

Google scholar

🎓 Education

Dr. Warland holds a PhD in Medicine (Health Sciences) from the University of Adelaide (2007), which cemented her focus on maternal and fetal health research. She also earned a Graduate Certificate in Education (University Teaching) from UniSA in 2009, highlighting her commitment to academic excellence. Additionally, she became a Registered Midwife in 1989 at the Queen Victoria Hospital, South Australia (now WCH). These educational milestones laid a strong foundation for her blended career in research, teaching, and clinical practice. Her qualifications reflect a lifelong dedication to improving outcomes in maternity care and advancing midwifery education. 🎓📖

💼 Experience

Dr. Warland’s professional journey includes decades as a Registered Nurse and Midwife from 1988 to 2007, serving in prominent South Australian hospitals. Transitioning into academia in 2008, she has held roles from Lecturer to Associate Professor, teaching research, midwifery practice, and perinatal health. Notably, she was Joint Chair at Curtin University/King Edward Memorial Hospital (2021–2023). At UniSA, she coordinated multiple courses and mentored students in midwifery and health sciences. Her dual experience in hands-on clinical care and academic leadership has significantly shaped maternal health education and policy across Australia. 🏥📘

🏆 Awards & Honors

While specific award titles are not explicitly listed, Dr. Warland’s long-standing leadership positions, joint academic chair roles, and continued appointments at major Australian universities highlight her recognition as a leading expert in her field. Her impact in stillbirth research and health communication strategies for pregnant women has earned her respect in national and international maternal health circles. Through honors such as research supervision, course coordination, and invitations to collaborative roles, she has consistently demonstrated academic excellence and professional dedication in midwifery science. 🏅🌟

🔬 Research Focus

Dr. Warland’s research primarily centers on stillbirth prevention, perinatal mental health, pregnancy health messaging, maternal sleep positions, and fetal well-being. Her interdisciplinary approach explores how behavioral and environmental factors influence pregnancy outcomes. She has supervised research on health communication, anxiety reduction in pregnant women, and fetal health awareness. With expertise spanning both psychology and midwifery, she bridges research with real-world applications to improve prenatal care. Her scholarship contributes to national awareness campaigns and informs guidelines for safer pregnancies. 🧠👶📊

Publication Top Notes

📚 Maternal sleep during pregnancy and poor fetal outcomes: a scoping review – 228 citations, 2018 🔍🍼
📚 Help-seeking for mental health problems in young refugees – 208 citations, 2009 🧠🌍
📚 Bearing witness: midwives experiences of witnessing traumatic birth – 177 citations, 2013 🍼😔
📚 Leadership in learning and teaching in higher education – 137 citations, 2015 🎓👩‍🏫
📚 Seeing and holding a stillborn baby: Mothers’ feelings – 119 citations, 2013 💔🍼
📚 Evidence for nursing practice – 118 citations, 2005 📘🩺
📚 STARS cohort study on late stillbirth experiences – 107 citations, 2015 👩‍🍼🌐
📚 Parenting paradox: parenting after infant loss – 103 citations, 2011 👨‍👩‍👧‍👦💔
📚 Umbilical cord characteristics and adverse outcomes – 85 citations, 2020 🔬🧬
📚 A triple risk model for unexplained late stillbirth – 84 citations, 2014 ⚠️🍼
📚 Understanding stillbirth stigma – 79 citations, 2020 🗣️🧠
📚 Assertiveness training for midwifery students – 77 citations, 2014 🧑‍⚕️🗯️
📚 Untold stories of infant loss – 76 citations, 2013 🍼💬

Liancheng Zhu | Medicine and Dentistry | Best Researcher Award

Published on 02/04/2025 by Global Academic Awards

Prof. Liancheng Zhu | Medicine and Dentistry | Best Researcher Award

Prof. Liancheng Zhu , Medicine and Dentistry , China Medical University, China

Dr. Zhu Liancheng is a highly respected professor of Obstetrics and Gynecology at Shengjing Hospital of China Medical University in Shenyang, Liaoning Province, China. He earned his doctor’s degree in Obstetrics and Gynecology from China Medical University.Dr. Zhu has a deep commitment to advancing women’s health through his expertise in gynecologic oncology, particularly in ovarian and endometrial cancers. With a distinguished career in clinical practice and research, he has contributed significantly to the study of molecular markers, gene expression profiles, and cancer treatment strategies in gynecological malignancies. His work has been published in leading international medical journals, and his research has garnered attention for its impact on cancer prognostication and therapeutic approaches. Dr. Zhu’s ongoing research continues to influence gynecologic oncology, focusing on improving cancer detection, prognosis, and treatment in women worldwide.

Publication Profile

Scopus

Academic Background🎓

Dr. Zhu Liancheng completed his medical education at China Medical University, Liaoning Province, China, where he earned his Doctor’s degree in Obstetrics and Gynecology in 2015. His academic foundation in gynecology was followed by extensive training and research in the field of women’s reproductive health, particularly focusing on gynecologic oncology. Dr. Zhu’s education has provided him with the expertise to explore the molecular and clinical aspects of gynecologic cancers, such as ovarian and endometrial cancers. He has undertaken advanced studies in cancer genomics, tumor markers, and the molecular mechanisms behind chemoresistance, with particular emphasis on gene expression analysis. This rigorous academic background has enabled him to make meaningful contributions to both clinical practice and the advancement of medical knowledge in the field of obstetrics and gynecology. His work has led to multiple publications and a broad recognition in the field of gynecologic cancer research.

Professional Background🏅

Dr. Zhu Liancheng is a professor in Obstetrics and Gynecology at Shengjing Hospital of China Medical University, where he has gained significant experience in both clinical practice and research. His clinical expertise includes diagnosing and treating complex gynecological conditions, particularly cancers such as ovarian, endometrial, and cervical cancers. He has contributed to the development of treatment protocols and strategies aimed at improving patient outcomes in gynecologic oncology. Dr. Zhu has also been deeply involved in translational research, studying molecular biomarkers and gene expression profiles that influence cancer progression and chemoresistance. His research has provided insights into the genetic mechanisms behind cancer prognosis and the development of targeted therapies. His role as a mentor for medical students, residents, and researchers further underscores his leadership in advancing gynecologic oncology. With a strong clinical and academic foundation, Dr. Zhu continues to make a significant impact on both patient care and scientific advancements.

Awards and Honors🏆

Dr. Zhu Liancheng’s outstanding contributions to the field of Obstetrics and Gynecology, particularly in gynecologic oncology, have earned him recognition from both national and international medical communities. Although specific awards are not listed, his extensive publication record, including numerous influential articles in leading medical journals, underscores his recognition as an expert in the field. His research on ovarian and endometrial cancers, gene expression profiles, and treatment resistance has been widely cited, demonstrating the impact of his work. Dr. Zhu has been invited to present at various national and international conferences, further solidifying his status as a thought leader in gynecologic oncology. Additionally, his role in advancing clinical practices and contributing to the development of prognostic tools for cancer patients reflects the high regard in which he is held by his peers. Dr. Zhu’s work continues to influence the future of gynecologic cancer research and treatment.

Research Focus🔬

Dr. Zhu Liancheng’s research primarily focuses on the molecular mechanisms behind gynecological cancers, with particular emphasis on ovarian and endometrial cancers. His work aims to identify novel biomarkers and genetic profiles that can predict cancer prognosis, progression, and response to therapy. Through gene expression analysis and the study of various molecular markers, Dr. Zhu seeks to enhance the understanding of how these cancers develop and metastasize, particularly focusing on chemoresistance and the role of tumor-associated genes. His research has contributed to identifying potential therapeutic targets, such as human epididymis protein 4 (HE4) and α1,2-fucosyltransferase (FUT1), which may offer new approaches to cancer treatment. Dr. Zhu’s work in gynecologic oncology is essential for improving the survival rates and quality of life for women with ovarian and endometrial cancers. His research also bridges the gap between laboratory findings and clinical applications, offering new hope for more effective treatment strategies in gynecological oncology.

Publication Top Notes

Integration of scRNA-seq and bulk RNA-seq to reveal the association and potential molecular mechanisms of metabolic reprogramming regulated by lactylation and chemotherapy resistance in ovarian cancer

Erratum: Retraction notice to “Downregulation of Rab23 inhibits proliferation, invasion, and metastasis of human ovarian cancer”

Corrigendum: SERPIND1 affects the malignant biological behavior of epithelial ovarian cancer via the PI3K/AKT pathway: a mechanistic study

Ferroptosis: mechanism, immunotherapy and role in ovarian cancer

Coordination of Single-cell and Bulk RNA Sequencing to Construct a Cuproptosis-related Gene Prognostic Index for Endometrial Cancer Prognosis, Immune Microenvironment Infiltration, and Immunotherapy Treatment Options

Citations: 2

Identification of a pyroptosis-related long non-coding RNA Signature for prognosis and its related ceRNA regulatory network of ovarian cancer

Citations: 5

Prognosis, Immune Microenvironment Infiltration and Immunotherapy Response in Clear Cell Renal Cell Carcinoma Based on Cuproptosis-related Immune Checkpoint Gene Signature

Citations: 2

Conclusion

Dr. Zhu Liancheng is highly deserving of the “Best Researcher Award” due to his outstanding and impactful research in the field of gynecologic oncology. His contributions to understanding the molecular underpinnings of ovarian and endometrial cancers, particularly his work on gene expression profiles and chemotherapy resistance, have had a profound impact on the field. His research not only furthers the understanding of cancer biology but also provides insights that could lead to better treatments and improved survival rates for women with these cancers. Dr. Zhu’s combination of clinical expertise, innovative research, and dedication to advancing women’s health positions him as a leader in his field. The breadth and depth of his work, coupled with his extensive publication record, make him a deserving candidate for this prestigious recognition. His influence on the future of gynecologic oncology is immense, and he continues to inspire and lead groundbreaking research efforts in the medical community.

Serpil Demir-Tuna | Physical Medicine | Women Researcher Award

Published on 26/03/202526/03/2025 by Global Academic Awards

Assoc. Prof. Dr. Serpil Demir-Tuna | Physical Medicine | Women Researcher Award

Assoc. Prof. Dr. Serpil Demir-Tuna, Akdeniz University Faculty of Medicine, Turkey

Assoc. Prof. Dr. Serpil Demir-Tuna is a distinguished physician specializing in Physical Medicine and Rehabilitation at Akdeniz University School of Medicine, Antalya, Turkey. With a career spanning over two decades, she has made significant contributions to aging, sarcopenia, musculoskeletal ultrasound, and osteoarthritis. Dr. Demir-Tuna has published extensively in top-tier medical journals, exploring the intersections of muscle health, joint disorders, and AI-driven solutions in healthcare. Her expertise extends to rheumatologic conditions, neuropathic pain, and metabolic syndrome in arthritis patients. She has been actively involved in clinical research, contributing valuable insights into the diagnosis and treatment of musculoskeletal disorders. A dedicated educator, she mentors young medical professionals while continuing her research on rehabilitation strategies for aging populations. Dr. Demir-Tuna’s work is widely recognized, earning her numerous accolades in the medical community. 📚🏆

Publication Profile

Orcid

Education 🎓

Dr. Serpil Demir-Tuna pursued her medical education at Ege University School of Medicine, graduating in 1999. She further specialized in Physical Medicine and Rehabilitation at Akdeniz University Medical School, where she completed her residency in 2005. Her academic training provided a strong foundation in musculoskeletal medicine, rehabilitation techniques, and pain management strategies. Throughout her education, she gained extensive clinical experience in diagnosing and treating neuromuscular and joint disorders, with a particular focus on sarcopenia, osteoarthritis, and musculoskeletal ultrasound applications. She actively participated in research programs, contributing to advancements in age-related muscle loss and innovative rehabilitation approaches. Her commitment to continuous learning has led her to attend numerous specialized training programs and workshops in AI applications in medicine, rheumatology, and pain management. This rigorous academic background has shaped her into an expert in the field of rehabilitation and aging-related musculoskeletal conditions. 📖🔬

Experience 💼

Dr. Serpil Demir-Tuna has been a dedicated physician, researcher, and educator at Akdeniz University Medical School, Department of Physical Medicine and Rehabilitation since 2005. With a strong focus on musculoskeletal health and aging, she has led numerous clinical trials and research projects exploring sarcopenia, osteoarthritis, and the role of musculoskeletal ultrasound in diagnostics. She has been instrumental in training medical students, residents, and fellows in the latest rehabilitation techniques. Over the years, she has developed innovative rehabilitation protocols for patients with chronic musculoskeletal conditions, neuropathic pain, and metabolic disorders. In addition to her academic responsibilities, she has served as a reviewer for international medical journals, evaluating research on rehabilitation strategies and musculoskeletal health. Her expertise in AI-driven healthcare solutions and commitment to evidence-based medicine have positioned her as a leader in the field of rehabilitation medicine and aging research. 🏥📊

Awards & Honors 🏅

Dr. Serpil Demir-Tuna has received multiple awards for her outstanding contributions to Physical Medicine and Rehabilitation. Her research on sarcopenia and osteoarthritis has been recognized with prestigious research grants and best paper awards at international conferences. She has been honored by medical societies and academic institutions for her groundbreaking work on muscle health, joint disorders, and AI-driven solutions in rehabilitation. Her role as a distinguished educator has earned her teaching excellence awards, highlighting her impact on medical education and mentorship. She has also been recognized for her collaborative research efforts in rheumatology and musculoskeletal disorders, receiving accolades for her work on metabolic syndrome in arthritis patients. As a thought leader in rehabilitation medicine, she has been invited as a keynote speaker at global medical symposia, further solidifying her reputation as a pioneer in musculoskeletal research. 🏆📚

Research Focus 🔬

Dr. Serpil Demir-Tuna’s research primarily focuses on aging-related musculoskeletal conditions, with an emphasis on sarcopenia, osteoarthritis, and musculoskeletal ultrasound. She investigates the pathophysiology of muscle loss in aging populations and explores novel rehabilitation strategies to improve muscle function and mobility. Her work also delves into the relationship between cartilage health and metabolic disorders, uncovering links between femoral cartilage thickness and knee osteoarthritis. She has contributed significantly to neuropathic pain research, identifying its prevalence in osteoarthritis patients. Additionally, she has explored the role of AI-driven healthcare solutions in managing sarcopenia and nutrition-related disorders. Her studies on inflammatory markers and autoimmune diseases provide insights into conditions like Behçet’s disease and Sjögren’s syndrome. Through her multidisciplinary research approach, she continues to shape the future of rehabilitation medicine with innovative diagnostic and treatment methodologies. 🏥🧬

Publication Top Notes

🦵 Relationship Between Sarcopenia, Femoral Cartilage Thickness, and Knee Osteoarthritis: Case–Control Study | International Journal of Rheumatic Diseases | 2025 | DOI: 10.1111/1756-185X.70179
🩸 Neuropathic Pain in Knee Osteoarthritis: Prevalence, Diagnosis, and Clinical Implications | Joint Diseases and Related Surgery | 2025 | DOI: 10.52312/jdrs.2025.1979
💤 Is There an Association Between Restless Legs Syndrome and Urticaria? | Journal of Korean Medical Science | 2016 | DOI: 10.3346/jkms.2016.31.5.790

Conclusion

Assoc. Prof. Dr. Serpil Demir-Tuna’s dedication to research, academic leadership, and clinical expertise makes her a strong candidate for the Women Researcher Award. Her innovative contributions in the field of Physical Medicine and Rehabilitation exemplify the award’s purpose of recognizing excellence in research.

Pingping Cai | Medicine | Best Researcher Award

Published on 11/03/202511/03/2025 by Global Academic Awards

Dr. Pingping Cai | Medicine | Best Researcher Award

Professor at Shandong Provincial Hospital Affiliated to Shandong First Medical University, China

Prof. Pingping Cai is a distinguished expert in Traditional Chinese Medicine (TCM), specializing in gynecological and reproductive health. She is a Professor at the Department of Traditional Chinese Medicine, Shandong Provincial Hospital Affiliated to Shandong First Medical University, China. With a Ph.D. in Gynecology of TCM from Guangzhou University of Chinese Medicine, her research focuses on TCM treatments for infertility, gynecological tumors, pregnancy disorders, breast diseases, and reproductive endocrine diseases. Prof. Cai has published extensively in peer-reviewed journals and actively contributes to advancing TCM-based therapies. Her expertise integrates classical TCM principles with modern biomedical approaches, making significant contributions to women’s health. She has received numerous accolades for her research and clinical excellence. 🌿🏥📚

Publication Top Notes

scopus

🎓 Education

Prof. Pingping Cai earned her Ph.D. in Gynecology of TCM from Guangzhou University of Chinese Medicine (2003-2006), where she focused on integrating classical Chinese medical theories with modern gynecological treatments. She completed her Master’s degree in Gynecology of TCM at Shandong University of Traditional Chinese Medicine (2000-2003), deepening her expertise in diagnosing and treating gynecological disorders using herbal medicine and acupuncture. Her Bachelor’s degree in Chinese Medicine from the same university (1992-1997) laid a strong foundation in TCM principles, pulse diagnosis, and herbal formulations. Throughout her academic journey, she gained extensive knowledge in reproductive endocrinology, pregnancy-related disorders, and the holistic management of female health conditions. Her education was enriched by hands-on clinical training and research in renowned hospitals, allowing her to develop innovative TCM-based approaches for treating complex gynecological diseases. Her academic excellence and research contributions have significantly shaped the integration of TCM into modern medical practice. 🎓📖🌱

💼 Experience

Since 2006, Prof. Pingping Cai has been serving as a Professor in the Department of Traditional Chinese Medicine at Shandong Provincial Hospital Affiliated to Shandong First Medical University, where she specializes in treating infertility, gynecological tumors, and pregnancy-related conditions using TCM. She plays a crucial role in integrating TCM with modern gynecology, mentoring young researchers, and advancing clinical methodologies. Before her current role, she worked at Qingdao Licang District Hospital (1997-2000) in the Department of Chinese Medicine, focusing on herbal formulations and acupuncture therapies for women’s health issues. Her clinical expertise includes managing polycystic ovary syndrome (PCOS), endometriosis, and menopause symptoms through personalized herbal prescriptions. She has contributed to numerous hospital-based research projects and collaborated with multidisciplinary teams to enhance the efficacy of TCM treatments. Her commitment to innovation and evidence-based practice has made her a leading figure in TCM gynecology. 🏥🌿👩‍⚕️

🏅 Awards & Honors

Prof. Pingping Cai has received numerous awards for her contributions to Traditional Chinese Medicine and women’s health. She has been honored with the Outstanding Researcher Award in TCM Gynecology for her groundbreaking studies on herbal treatments for infertility. She was recognized by the Chinese Society of Traditional Medicine for her advancements in integrating TCM with reproductive endocrinology. Her work on the role of TCM in treating ovarian disorders earned her the Best Clinical Innovation Award. She also received the Excellence in Academic Publishing Award for her high-impact research papers in leading medical journals. Additionally, her contributions to education and mentorship have been acknowledged with the Distinguished Educator Award. She has been invited as a keynote speaker at international TCM conferences and serves as an editorial board member for several prestigious journals. Her dedication to advancing TCM in gynecological health continues to inspire the next generation of practitioners. 🏆📜🌏

🔬 Research Focus

Prof. Pingping Cai specializes in the Traditional Chinese Medicine treatment of gynecological and reproductive disorders. Her research focuses on TCM-based therapies for infertility, exploring the effects of herbal medicine and acupuncture on reproductive health. She investigates the role of TCM in treating gynecological tumors, examining herbal formulations that regulate tumor growth and immune responses. She is also dedicated to studying TCM interventions for pregnancy complications, including miscarriage prevention and fetal development. Her work on breast diseases highlights the effectiveness of TCM in managing mastitis and hormonal imbalances. Another key area of her research is the treatment of reproductive endocrine diseases, where she explores the impact of TCM on hormonal regulation in conditions like polycystic ovary syndrome (PCOS) and premature ovarian failure. Through clinical trials and molecular research, she aims to bridge traditional practices with modern medical advancements. Her contributions significantly enhance the understanding and application of TCM in gynecology. 🌿🩺📊

Publication Top Notes

Xu Y, Li Y, Zhang J, Cai P. “Hua Yu Xiao Zheng decoction induces ectopic endometrial stromal cell senescence via inhibiting the PI3K/AKT signaling.” Tissue Cell. 2025 Apr;93:102763.

scholar.google.com
Shao W, Lin Z, Xiahou Z, Zhao F, Xu J, Liu X, Cai P. “Single-cell RNA sequencing reveals that MYBL2 in malignant epithelial cells is involved in the development and progression of ovarian cancer.” Front Immunol. 2024 Jul 29;15:1438198.

scholar.google.com
Wang Y, Cai P, Qi F. “Examination and analysis of the disease evidence of ‘retention of placenta’.” China Journal of Basic Medicine in Traditional Chinese Medicine. 2024;30(10):1633-1637.

scholar.google.com
Wang Z, Cai P. “Cai Pingping’s experience in treating subchorionic hematoma based on the Eight Principles of Syndrome Differentiation.” Shanghai Journal of Traditional Chinese Medicine. 2024;58(04):54-57.

scholar.google.com
Yan R, He J, Xue Y, Wang Y, Dong R, Cai P. “Study on the dosage pattern of Chinese herbal enema formula for the treatment of sequelae of pelvic inflammatory diseases.” Chinese Traditional Patent Medicine. 2024;46(10):3492-3496.

scholar.google.com
Su N, Cai P, Dou Z, Yin X, Xu H, He J, Li Z, Li C. “Brain nuclei and neural circuits in neuropathic pain and brain modulation mechanisms of acupuncture: a review on animal-based experimental research.” Front Neurosci. 2023 Aug 30;17:1243231.

scholar.google.com
Wang Y, Qiu H, Yan R, Jing W, Li J, Cai P. “Mechanisms associated with the treatment of premature ovarian insufficiency by Zuogui Pill’s formula based on differential analysis of microRNAs and network pharmacology.” Chinese Archives of Traditional Chinese Medicine. 2023;41(04):81-86+269-273.

scholar.google.com
Wang Y, Yan R, Jing W, Cai P. “Investigating the mechanisms of Bei Sha Shen-Yu Zhu in the treatment of premature ovarian failure based on network pharmacology and molecular docking technique.” Traditional Chinese Drug Research and Clinical Pharmacology. 2022;33(05):645-654.

scholar.google.com
Wang Z, Qi F, Cui Y, Zhao L, Sun X, Tang W, Cai P. “An update on Chinese herbal medicines as adjuvant treatment of anticancer therapeutics.” Biosci Trends. 2018;12(3):220-239.

scholar.google.com
Cai P, Liu X, Xu Y, Qi F, Si G. “Shenqi detoxification granule combined with P311 inhibits epithelial-mesenchymal transition in renal fibrosis via TGF-β1-Smad-ILK pathway.” Biosci Trends. 2017;11(6):640-650.

scholar.google.com

Rutu Rathod | Public Health | Best Researcher Award

Published on 31/12/202431/12/2024 by Global Academic Awards

Dr. Rutu Rathod | Public Health | Best Researcher Award

Dr. Rutu Rathod, University of Arkansas for Medical Sciences, United States

🎓 Dr. Rutu A. Rathod, PhD, MPH, MBBS is an Assistant Professor of Epidemiology at the Fay W. Boozman College of Public Health, University of Arkansas for Medical Sciences, and a member of the Cancer Prevention and Population Sciences Program at the Winthrop P. Rockefeller Cancer Institute. She earned her PhD in Epidemiology from the University of Memphis, MPH from Texas A&M University, and MBBS from Sumandeep Vidyapeeth University, India. Dr. Rathod specializes in cancer epidemiology, DNA methylation, and health disparities. With numerous publications, honors, and funded research projects, she is advancing the understanding of social determinants of health and their impact on chronic diseases. 📊🌎

Publication Profile

Google Scholar

Academic Journey 🎓

Dr. Rutu Rathod is a dedicated public health professional with a strong academic foundation. She earned her Ph.D. in Epidemiology in 2021 from the University of Memphis, specializing in Biostatistics and Environmental Health Sciences. Prior to this, she completed her Master of Public Health (MPH) in Epidemiology in 2018 at Texas A&M University, gaining expertise in epidemiological research and biostatistical methods. Dr. Rathod began her academic journey with a Bachelor of Medicine and Bachelor of Surgery (MBBS) degree in 2015 from Sumandeep Vidyapeeth University, India, laying the groundwork for her career in healthcare and research. 🌍📊🔬

Professional Experiences

Dr. Rutu Rathod is an accomplished epidemiologist with diverse professional experiences. Currently, she serves as an Assistant Professor (Tenure-track) at the Fay W. Boozman College of Public Health, University of Arkansas for Medical Sciences, and as a member of the Cancer Prevention and Population Sciences Program at the Winthrop P. Rockefeller Cancer Institute. She is also an Adjunct Assistant Professor at the University of Texas Southwestern Medical Center. Her prior roles include Graduate Research Assistantships, focusing on DNA methylation, asthma, obesity, and prenatal alcohol exposure, as well as clinical roles as a physician and intern in India. 🧬🩺📚

Honors and Awards

Dr. Rutu Rathod has received numerous accolades for her contributions to public health and academic research. She earned the prestigious Gold Medallion as a Public Health Scholar at Texas A&M University in 2018. At the University of Memphis, she was recognized with the Student Accomplishment Award (2021) and multiple travel awards (2019-2020). Dr. Rathod also secured second place at the 32nd Annual Student Research Forum (2020) in Life and Health Sciences and received the School of Public Health Student Achievement Award. Her dedication to research and excellence is further highlighted by awards from the Department of Neuroscience. 🎓🏆📊

Research Focus

Dr. Rutu Rathod’s research centers on the intersection of epigenetics and respiratory health. Her work explores how DNA methylation mediates the impact of early-life BMI trajectories on asthma and lung function in adulthood. She investigates sex-specific associations between asthma and epigenetic changes, the role of methylation in coronavirus-related gene expression, and chronic disease risk factors like myocardial infarction. Dr. Rathod contributes significantly to understanding gene-environment interactions and their effects on respiratory conditions, with a focus on using epigenetic markers for disease prediction and prevention. Her research bridges epidemiology and molecular biology. 📊🩺📖

Publication Top Notes

Sex‐specific associations of asthma acquisition with changes in DNA methylation during adolescence (29 citations, 2021) 📄🧬
BMI trajectory in childhood is associated with asthma incidence at young adulthood mediated by DNA methylation (18 citations, 2021) 📊🌬️
Methylation of host genes associated with coronavirus infection from birth to 26 years (9 citations, 2021) 🦠🧬
Association of childhood BMI trajectory with post-adolescent and adult lung function mediated by pre-adolescent DNA methylation (7 citations, 2022) 📈🌬️
Association of asthma and rhinitis with epigenetics of coronavirus-related genes (5 citations, 2021) 🤧🧬
BMI trajectory in childhood is associated with asthma incidence at young adulthood mediated by DNA methylation (1 citation, 2021) 📊🩺
Epidemiological Studies on Risk Factors of Chronic Diseases (No citations, 2021) 📘📊
Risk factors of myocardial infarction at later age in healthy middle-aged men (No citations, 2020) 🫀📊
The Association of Asthma Acquisition with DNA Methylation Changes During Adolescence Is Gender-Specific (No citations, 2020) 🧬👩‍⚕️
Association of BMI Trajectory in Earlier Childhood with Lung Function in Adulthood Mediated by DNA Methylation (No citations, 2020) 📈🌬️
BMI Trajectory in Childhood Associated with Asthma at Young Adulthood Mediated by DNA Methylation (No citations, 2019) 🧬📊

Arezou Mehrabi | biomedical science | Best Researcher Award

Published on 28/10/202428/10/2024 by Global Academic Awards

Assist. Prof. Dr Arezou Mehrabi | biomedical science | Best Researcher Award

Assist. Prof. Dr, Islamic Azad University – Tonekabon Branch, Iran

Arezou Mehrabi, born in Mazandaran, Iran, is a tissue engineering researcher known for her innovative work in biomedical materials. She completed her Ph.D. in Tissue Engineering at Iran University of Medical Sciences, focusing on bioactive hydrogels for wound healing. With a strong foundation in anatomical science (M.Sc.) from Tarbiat Modares University and a B.Sc. in Radiology from Mashhad University of Medical Sciences, Mehrabi’s research is primarily devoted to advancing regenerative medicine, particularly for cardiac and bone tissue applications. Her work includes various publications and collaborations, shaping her as a prominent figure in tissue engineering.

Publication Profile

scholar

Education 🎓

Mehrabi obtained her Ph.D. in Tissue Engineering from Iran University of Medical Sciences (2018-2023), presenting a thesis on in-situ forming hydrogels for wound healing. Previously, she earned an M.Sc. in Anatomical Science (2015-2017) from Tarbiat Modares University, focusing on electroactive carbon nanofiber cardiac patches. Her academic journey began with a B.Sc. in Radiology at Mashhad University of Medical Sciences (2011-2015). These academic credentials provided a strong multidisciplinary background, supporting her expertise in biomedical and tissue engineering.

Experience 💼

Mehrabi’s professional experience includes significant contributions to tissue engineering, with a specialization in electroactive and bioactive hydrogels. Her research has focused on applications in cardiac and bone regeneration, including projects on nanofiber cardiac patches and electroconductive scaffolds. She has collaborated on diverse projects and has presented her findings at numerous international conferences. Her work has also led to the development of patents in electroactive cardiac patches and innovative biomaterials for regenerative medicine.

Awards and Honors 🏆

Mehrabi has earned recognition for her contributions, including a certified patent for an electroactive cardiac patch awarded by the Iranian Research Organization for Science and Technology (IROST, Patent No. 94280). She has also co-authored influential studies and book chapters and contributed to significant scientific publications. Her dedication to research has positioned her as a key innovator in tissue engineering, especially in developing new materials for cardiac and bone tissue engineering.

Research Focus 🔬

Mehrabi’s research is centered on biomaterials for tissue engineering, with a focus on bioactive and electroactive materials for cardiac and wound healing applications. Her notable projects include developing carbon nanofiber-based cardiac patches and hydrogels that promote vascularization and regeneration. Mehrabi is also exploring advanced applications for natural polymers in cancer diagnosis and treatment. Her work in regenerative medicine aims to advance sustainable, innovative solutions for therapeutic applications in healthcare.

Publication Top Notes

Electroactive Cardiac Patch
Development of a novel electroactive cardiac patch based on carbon nanofibers and gelatin encouraging vascularization
A. Mehrabi, N. Baheiraei, M. Adabi, Z. Amirkhani
Applied Biochemistry and Biotechnology 190, 931-948, 47 citations (2020)

In-Situ Hydrogel for Wound Healing
In-situ forming hydrogel based on thiolated chitosan/carboxymethyl cellulose (CMC) containing borate bioactive glass for wound healing
A. Mehrabi, A. Karimi, S. Mashayekhan, A. Samadikuchaksaraei, PB Milan
International Journal of Biological Macromolecules 222, 620-635, 26 citations (2022)

Hydrogel for Breast Reconstruction
Synthesis and characterization of a silk fibroin/placenta matrix hydrogel for breast reconstruction
A. Mehrabi, S. Mousazadeh, A. Mollafilabi, N. Nafissi, PB Milan
Life Sciences 334, 122236, 7 citations (2023)

Bone Tissue Engineering
Evaluation of inherent properties of the carboxymethyl cellulose (CMC) for potential application in tissue engineering focusing on bone regeneration
A. Mehrabi, SZ Jalise, A. Hivechi, S. Habibi, MM Kebria, MA Haramshahi
Polymers for Advanced Technologies 35 (1), e6258, 5 citations (2024)

Vasculogenesis and Angiogenesis
Molecular mediators of vasculogenesis and angiogenesis
M. Amoupour, MM Kebria, A. Hivechi, N. Peyravian, M. Ghasemian
Biomaterials for Vasculogenesis and Angiogenesis, 13-37, 5 citations (2022)

Cell Sources in Cardiac Tissue Engineering
Cell sources in cardiac tissue engineering: current choices
PB Milan, N. Amini, A. Mehrabi, S. Mousazadeh, S. Ababzadeh, A. Rezapour
Current Stem Cell Research & Therapy 16 (6), 745-752, 5 citations (2021)

Electroconductive Scaffolds
Electroconductive Scaffolds: A New Strategy in Cardiac Tissue Engineering
A. Mehrabi, N. Baheiraei
Pathobiology Research 21 (2), 107-111, 2 citations (2018)

Natural Polymers in Cancer Treatment
Natural polymers for diagnosis and treatment of cancers
A. Mehrabi, R. Najafloo, H. Valizadeh, VH Sarmadi, S. Naderi
Biomaterials for Precision Cancer Medicine, 123-153, 2025

In Situ Fibrin Scaffold for Bone Engineering
Development of in situ forming autologous fibrin scaffold incorporating synthetic teriparatide peptide for bone tissue engineering
MR Khalili, A. Molafilabi, S. Mousazadeh, A. Mehrabi, J. Kiani
The International Journal of Artificial Organs, 2024

Morphine’s Effects on the CNS
The effects of morphine administration on the central nervous system (CNS): advantages and disadvantages
A. Mehrabi, BL Aghaee, S. Farrokhfar
Neuroscience Research Notes 7 (2), 2024

Conclusion

Dr. Arezou Mehrabi is an exceptional candidate for the Best Researcher Award, with extensive expertise in tissue engineering and biomedical science. Her dedication to pioneering research in tissue engineering, particularly in wound healing and cardiac applications, as well as her solid publication and patent record, highlight her as a leading scientist in her field. While there are areas where expanding international collaboration and public outreach could further amplify her impact, Dr. Mehrabi’s innovative approach, academic accomplishments, and contributions to practical medical solutions make her highly deserving of recognition as a top researcher.

Rasheedat Balogun | Obstetric Haemorrhage | Best Researcher Award

Published on 07/10/202407/10/2024 by Global Academic Awards

Dr. Rasheedat Balogun | Obstetric Haemorrhage | Best Researcher Award

Dr. Rasheedat Balogun, University College Hospital Ibadan/ Fertpromax Consult, Nigeria

Dr. Rasheedat Omolola Balogun 🎓 is a distinguished Consultant Gynaecologist and Fertility Specialist at Fertpromax Consult, Lagos, Nigeria. With an MB; BS from the University of Ibadan (2013), she excelled as the Best Graduating Student in Surgery. Dr. Balogun has received multiple accolades, including Overall Best Candidate and Best Female Candidate in Obstetrics & Gynaecology from the West African College of Surgeons (2020). Her research contributions include publications in prominent journals, focusing on pregnancy-related cases.

Publication profile

Orcid

Educational Background

Dr. Rasheedat Omolola Balogun holds a distinguished educational background in medicine and surgery. She earned her MB; BS degree from the University of Ibadan, College of Medicine, in 2013, where she graduated as the Best Graduating Student in Surgery. In 2020, she became a member of the West African College of Surgeons (MWACS) in Obstetrics and Gynaecology. Recently, in 2023, Dr. Balogun attained the Fellow of the Medical College of Obstetrics and Gynaecology (FMCOG) designation from the National Postgraduate Medical College of Nigeria. Her foundational education was completed at the Federal Government College, Ijanikin, Lagos, where she earned her WASSC in 2005. 📚✨

Professional Experience

Dr. Rasheedat Omolola Balogun is a highly skilled Consultant Gynaecologist and Fertility Specialist at Fertpromax Consult in Gbagada, Lagos, since February 2024. Previously, she served as Chief Resident in Obstetrics and Gynaecology at University College Hospital (UCH), Ibadan, from November 2022 to October 2023. Dr. Balogun also held the position of Senior Resident in the Assisted Conception Unit (IVF) at UCH from December 2020 to October 2023 and completed her residency in Obstetrics and Gynaecology from 2017 to 2020. Her medical journey began as a House Officer at UCH (2013-2014), with roles as a Medical Officer at several hospitals, including Get-Well Hospital and TZ Hospital. 🌟🏥

Dr. Rasheedat Omolola Balogun has received several prestigious awards in recognition of her outstanding contributions and achievements. In 2023, she was honored by University College Hospital (UCH), Ibadan, for her dedication and growth contributions to the hospital. She also earned the UCH Shalina Rising Star award, being recognized as one of the top six best residents’ dissertations and finishing as the first runner-up. Additionally, Dr. Balogun received the Professor Vincent Aimakhu Prize from the West African College of Surgeons in 2021 for being the best candidate in the 2020 membership examinations, along with the Eusebe Alihonou Prize for being the best female candidate. 🌟✨

Conclusion

Dr. Rasheedat Balogun embodies the qualities sought in a recipient of the Research for Best Researcher Award. Her exceptional educational achievements, extensive clinical experience, impactful research contributions, and recognition by peers demonstrate her unwavering commitment to the field of obstetrics and gynecology. She stands out as a candidate who not only contributes to medical science but also inspires future generations of healthcare professionals.

Publication Top Notes

A randomized controlled trial on the comparison of two doses of carbetocin with oxytocin for the prevention of postpartum hemorrhage (Concert Trial), Journal of Obstetrics and Gynaecology Research (2024) DOI: 10.1111/jog.16097 🩺
Assessment of anxiety and depression, and coping mechanisms during COVID-19 lockdown among pregnant women, Heliyon (2022) DOI: 10.1016/j.heliyon.2022.e10902 😷
Outcomes following cervical cerclage at the University College Hospital. A retrospective analysis, Conference paper (Year not specified) 📄

Pedro Antonio Regidor | Medicine and Dentistry | Best Innovation Award

Published on 18/09/202430/08/2025 by Global Academic Awards

Dr. Pedro Antonio Regidor | Medicine and Dentistry | Best Innovation Award

Dr. Pedro Antonio Regidor, Exeltis, Germany

Dr. Pedro Antonio Regidor holds dual German and Spanish citizenship. He completed his medical studies at the University of Essen and gained extensive experience in gynecology and obstetrics across Germany and Venezuela. Notably, he served as Medical Director at Exeltis Europe and Global Projects. His qualifications include specialized certifications in radiological diagnostics and gynecological endocrinology. Dr. Regidor is recognized for his contributions to women’s health and medical innovation. Currently, he continues his work as a Medical Director and private practitioner in Munich, Germany. 🌍💉

Publication profile

Scopus

Professional Background

Dr. Pedro Antonio Regidor, holding both German and Spanish citizenship, has a distinguished career in the field of gynecology and obstetrics. His educational journey began at the Deutsche Schule Madrid and continued with medical studies at the University of Essen, where he completed his state exams and medical training. His professional experience spans multiple countries and prestigious institutions, including roles as a senior physician and medical director at prominent medical centers in Germany.

Innovative Contributions

Dr. Regidor has demonstrated a commitment to advancing medical practice and patient care. His roles in various high-profile positions, including Medical Director at Exeltis Europe & Global Projects, reflect his leadership in implementing innovative practices and advancing healthcare delivery. His experience with cutting-edge medical technologies and practices, including his certifications in advanced diagnostic and therapeutic techniques, underscores his contributions to medical innovation.

Awards and Recognitions

Dr. Regidor’s career is marked by several significant recognitions, including his certifications in specialized fields such as radiological diagnostics and gynecological endocrinology. His role as a Medical Director involved overseeing global projects, indicating a strong track record of managing and implementing innovative solutions across diverse healthcare settings.

Publication Top Notes

“The drospirenone only pill as a contraceptive option for breastfeeding women: First data on users’ acceptability and newborn development” (Gynecological Endocrinology, 2024) 📅
“OPEN PROSPECTIVE STUDY TO EVALUATE THE EFFICACY OF A NEW VAGINAL PESSARY CONTAINING 300MG TINIDAZOLE, 200MG TIOCONAZOLE AND 100MG LIDOCAINE” (Reproductive Endocrinology, 2024) 📅
“Nausea and Vomiting of Pregnancy and its Management with the Dual-Release Formulation of Doxylamine and Pyridoxine” (Geburtshilfe und Frauenheilkunde, 2023) 📅
“Improvement in menopausal symptoms with a nutritional product containing evening primrose oil, hop extract, saffron, tryptophan, vitamins B6, D3, K2, B12, and B9” (European Review for Medical and Pharmacological Sciences, 2023) 📅
“10-month retrospective study on compliance and tolerability of the drospirenone-only pill” (European Review for Medical and Pharmacological Sciences, 2023) 📅
“Miconazole for the treatment of vulvovaginal candidiasis. In vitro, in vivo and clinical results. Review of the literature” (Journal of Obstetrics and Gynaecology, 2023) 📅
“Pharmacological and metabolic effects of drospirenone as a progestin-only pill compared to combined formulations with estrogen” (Women’s Health, 2023) 📅
“The drospirenone (DRSP)-only pill: clinical implications in the daily use” (European Journal of Contraception and Reproductive Health Care, 2023) 📅
“Erratum: Oral Progestins in Hormonal Contraception: Importance and Future Perspectives of a New Progestin Only-Pill Containing 4 mg Drospirenone” (Geburtshilfe und Frauenheilkunde, 2022) 📅
“Evaluation of the food effect on a drospirenone only contraceptive containing 4 mg administered with and without high-fat breakfast in a randomised trial” (BMC Women’s Health, 2022) 📅

Conclusion

Dr. Pedro Antonio Regidor’s extensive experience in gynecology, his leadership in implementing innovative healthcare practices, and his significant contributions to medical advancements, he is a strong candidate for the “Research for Best Innovation Award.” His career reflects a profound impact on medical practices and innovation, aligning well with the award’s criteria.